![Carl Tobias Sjöblom](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carl Tobias Sjöblom
Fundador en ExScale Biospecimen Solutions AB .
Perfil
Carl Tobias Sjöblom is the founder of ExScale Biospecimen Solutions AB, a company founded in 2012, where he holds the title of Director.
He is currently working as a Director at Oncodia AB.
Cargos activos de Carl Tobias Sjöblom
Empresas | Cargo | Inicio |
---|---|---|
ExScale Biospecimen Solutions AB
![]() ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Fundador | 01/01/2012 |
Oncodia AB
![]() Oncodia AB Packaged SoftwareTechnology Services Oncodia AB develops regulatory compliant software for mutation analysis in clinical diagnostics. The company is based in Uppsala, Sweden. The Swedish company was founded by Ivaylo Stoimenov. The CEO is Kristofer Maad. | Director/Miembro de la Junta | 01/01/2018 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
ExScale Biospecimen Solutions AB
![]() ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Health Technology |
Oncodia AB
![]() Oncodia AB Packaged SoftwareTechnology Services Oncodia AB develops regulatory compliant software for mutation analysis in clinical diagnostics. The company is based in Uppsala, Sweden. The Swedish company was founded by Ivaylo Stoimenov. The CEO is Kristofer Maad. | Technology Services |
- Bolsa de valores
- Insiders
- Carl Tobias Sjöblom